Cyclosporine before Coronary Artery Bypass Grafting Does Not Prevent Postoperative Decreases in Renal Function A Randomized Clinical Trial
Conclusions Administration of cyclosporine did not protect coronary artery bypass grafting patients from acute kidney injury. Instead, cyclosporine caused a decrease in renal function compared to placebo that resolved after 1 month.
Source: Anesthesiology - Category: Anesthesiology Source Type: research
More News: Anesthesia | Anesthesiology | Brain | Cardiology | Clinical Trials | Coronary Artery Bypass Graft | Heart | Neurology | Restasis | Study | Urology & Nephrology